EQUIPPED WITH 110
YEARS OF ACCUMULATIVE
EXPERIENCE.

SiHyoung Park
SiHyoung ParkDirector / Head of Venture Investment Division IV at SBI Investment KOREA
Profile
Equity Analyst of Bio/Pharmaceuticals at CGS-CIMB Securities
Equity Analyst of Bio/Pharmaceuticals at IBK Securities

Ph.D. in Systemsbiology from Yonsei University
BSc in Biology from Yonsei University
In charge of funds
□ Co-lead
- IBKC-SBI BIO FUND NO.1(30 billion KRW)
- 2014 KIF-SBI IT Venture Fund(30 billion KRW)
- SBI-KIS 2021 BIC(Best-In-Class) Fund 2(20.3 billion KRW)
- SBI-Growth Ladder Konex Vitalization Fund(40 billion KRW)
Introduction of message
Dr. Park Si-hyung joined SBI Investment KOREA based on his experience in the retail market, volume of re-trade, and knowledge of his major while working as an analyst at a local and foreign securities firm. We are primarily interested in new drug development, liquid biopsy, and deep learning modeling.